Kuipers Peter J.
- SEC CIK
- 0001651691
No open-market purchases or sales filed in the past year.
Current role at each company
- CLOV Clover Health Investments, Corp.Chief Financial Officeras of Feb 2, 2026
- IVC Invacare Holdings CorpDirectoras of Nov 3, 2023
- OMCL Omnicell, Inc.EVP, EXECUTIVE ADVISORas of Jun 16, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kuipers Peter J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OMCL Omnicell, Inc.
EVP, EXECUTIVE ADVISOR5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2022 (view filing) | Aug 26 | 4 days | Kuipers Peter J.EXECUTIVE V P& CFO | SSale | −15.5K | $108.29 | −$1.68M | −20.2%61.3K after | 2 lots |
| Aug 24, 2022 (view filing) | Aug 22 | 2 days | Kuipers Peter J.EXECUTIVE V P& CFO | SSale | −11.0K | $105.93 | −$1.17M | −15.2%61.3K after | |
| Dec 8, 2021 (view filing) | Dec 7 | 1 day | Kuipers Peter J.Executive V P& CFO | SSale | −8.52K | $181.15 | −$1.54M | −14.3%51.1K after | 5 lots |
| Aug 6, 2021 (view filing) | Aug 6 | Same day | Kuipers Peter J.Executive V P& CFO | SSale | −11.5K | $157.88 | −$1.82M | −17.6%54.0K after | 9 lots |
| Aug 3, 2021 (view filing) | Aug 2 | 1 day | Kuipers Peter J.Executive V P& CFO | SSale | −22.1K | $146.11 | −$3.23M | −27.0%59.8K after | 4 lots |